Home/Filings/4/0001437749-24-019349
4//SEC Filing

Lisjak Michael Eric 4

Accession 0001437749-24-019349

CIK 0000922247other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 5:11 PM ET

Size

5.2 KB

Accession

0001437749-24-019349

Insider Transaction Report

Form 4
Period: 2024-06-03
Lisjak Michael Eric
Chief Regulatory Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-03+110,732110,732 total
    Exercise: $1.28Exp: 2034-06-03Common Stock (110,732 underlying)
Footnotes (1)
  • [F1]The option vests over a one year period in equal quarterly installments.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001825761

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:11 PM ET
Size
5.2 KB